Viking Global Investors
CALA

Viking Global Investors’s Calithera Biosciences, Inc CALA Stock Holding History

Viking Global Investors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-82,184
Closed -$13.7M – 78
2017
Q4 		$13.7M Sell
82,184
-49,043
-37% -$12.6M 0.08% 56
2017
Q3 		$41.3M Buy
131,227
+10,211
+8% +$3.22M 0.27% 50
2017
Q2 		$35.9M Buy
121,016
+5,735
+5% +$1.53M 0.24% 49
2017
Q1 		$26.6M Buy
+115,281
New +$19.9M 0.12% 60

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors's CALA Position: Q1 2018 in Review

Viking Global Investors sold out of Calithera Biosciences, Inc (CALA) in Q1 2018, closing a stake of 82,184 shares — an estimated $13.7M sold.

Viking Global Investors first reported a position in CALA in Q1 2017 and held it in 4 quarters. The position peaked at $41.3M in Q3 2017. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2018.

  • Viking Global Investors reported no remaining Calithera Biosciences, Inc position as of Q1 2018 after selling out during the quarter.
  • Viking Global Investors sold 82,184 Calithera Biosciences, Inc shares in Q1 2018, an estimated $13.7M.
  • Viking Global Investors first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 4 quarters.
  • Viking Global Investors's Calithera Biosciences, Inc position peaked at $41.3M in Q3 2017.
  • 100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2018.

Based on Viking Global Investors's 13F filing for Q1 2018, filed 15 May 2018.